Edition:
United States

CVS Health Corp (CVS.N)

CVS.N on New York Stock Exchange

71.90USD
16 Feb 2018
Change (% chg)

$1.41 (+2.00%)
Prev Close
$70.49
Open
$70.37
Day's High
$72.20
Day's Low
$70.32
Volume
1,855,925
Avg. Vol
2,067,103
52-wk High
$84.00
52-wk Low
$66.46

Chart for

About

CVS Health Corporation, together with its subsidiaries, is an integrated pharmacy healthcare company. The Company provides pharmacy care for the senior community through Omnicare, Inc. (Omnicare) and Omnicare's long-term care (LTC) operations, which include distribution of pharmaceuticals, related pharmacy consulting and other... (more)

Overall

Beta: 0.97
Market Cap(Mil.): $72,834.16
Shares Outstanding(Mil.): 1,012.99
Dividend: 0.50
Yield (%): 2.84

Financials

  Industry Sector
P/E (TTM): -- 20.16 17.27
EPS (TTM): -- -- --
ROI: -- 11.61 35.43
ROE: -- 13.76 17.10

CVS pledges to reinvest much of its tax savings, shares fall

CVS Health Corp warned on Thursday that its operating profit could fall this year as it plans to spend most of its $1.2 billion savings from the new U.S. tax law on reducing debt and paying employees more rather than boosting short-term profit.

Feb 08 2018

UPDATE 4-CVS pledges to reinvest much of its tax savings, shares fall

Feb 8 CVS Health Corp warned on Thursday that its operating profit could fall this year as it plans to spend most of its $1.2 billion savings from the new U.S. tax law on reducing debt and paying employees more rather than boosting short-term profit.

Feb 08 2018

Cardinal Health profit beats on CVS tie-up, Medtronic unit buy

Cardinal Health's quarterly profit topped analysts' estimates as the U.S. drug distributor benefited from its purchase of Medtronic Plc's patient care business and a tie-up with drugstore chain CVS Health Corp .

Feb 08 2018

CVS says Aetna acquisition still expected in 2018

NEW YORK CVS Health Corp on Thursday said that a request for more information from U.S. antitrust regulators reviewing its proposed $69 billion acquisition of health insurer Aetna Inc does not impact its expectation that the deal will close in the second half of 2018.

Feb 08 2018

CVS says Aetna acquisition still expected in 2018

NEW YORK, Feb 8 CVS Health Corp on Thursday said that a request for more information from U.S. antitrust regulators reviewing its proposed $69 billion acquisition of health insurer Aetna Inc does not impact its expectation that the deal will close in the second half of 2018.

Feb 08 2018

BRIEF-CVS Health Sees Q1 2018 Net Revenue Growth For Retail/LTC Between 4 Pct To 5.5 Pct

* CVS HEALTH SEES PHARMACY SERVICES NET REVENUE CHANGE OF 1.5 PERCENT TO 3.5 PERCENT FOR FULL-YEAR 2018 - PRESENTATION SLIDES‍​

Feb 08 2018

BRIEF-CVS Health To Invest In Wage Increases And Benefits Following Tax Cuts and Jobs Act

* CVS HEALTH INVESTING IN LONG-TERM AND SUSTAINABLE WAGE INCREASES AND BENEFITS ENHANCEMENTS FOLLOWING THE PASSAGE OF THE TAX CUTS AND JOBS ACT

Feb 08 2018

CVS fourth quarter profit jumps in wake of U.S. tax law

NEW YORK, Feb 8 CVS Health Corp, which said in December it would buy health insurer Aetna Inc in a $69 billion deal, posted a jump in profit on Thursday, helped by savings from the biggest overhaul of the U.S. tax code in 30 years.

Feb 08 2018

Hudson's Bay names CVS Health veteran as new CEO

Saks Fifth Avenue-owner Hudson's Bay Co on Monday named veteran CVS Health Corp executive Helena Foulkes as its chief executive officer, replacing Richard Baker, who has been heading the company on an interim basis.

Feb 05 2018

UPDATE 1-Hudson's Bay names CVS Health veteran as new CEO

Feb 5 Saks Fifth Avenue-owner Hudson's Bay Co on Monday named veteran CVS Health Corp executive Helena Foulkes as its chief executive officer, replacing Richard Baker, who has been heading the company on an interim basis.

Feb 05 2018

Competitors

Earnings vs. Estimates